Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
February 12, 2024
Application of multistate modeling to clinical data analysis
Joachim Grevel, Joshua Veasy, Blesson Chacko
European Journal of Drug Metabolism and Pharmacokinetics
|
January 13, 2017
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
Roberta Bursi, Chiara Piana, Joachim Grevel, et al.
Clinical Pharmacokinetics
|
June 4, 2021
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Hauke Ruehs, Dagmar Klein, Matthias Frei, et al.
Clinical and Translational Science
|
March 29, 2019
Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer
Joachim Grevel, Garrit Jentsch, Rupert Austin, et al.
European Journal of Endocrinology
|
June 12, 2023
Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
Isabella Gashaw, Stefanie Reif, Herbert Wiesinger, et al.
Hepatology International
|
December 3, 2016
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Shi-Ming Lin, Sheng-Nan Lu, Ping-Tsung Chen, et al.
Molecular Cancer Therapeutics
|
October 18, 2019
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors
Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, et al.
The Lancet. Oncology
|
August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
February 12, 2024
Application of multistate modeling to clinical data analysis
Joachim Grevel, Joshua Veasy, Blesson Chacko
European Journal of Drug Metabolism and Pharmacokinetics
|
January 13, 2017
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
Roberta Bursi, Chiara Piana, Joachim Grevel, et al.
Clinical Pharmacokinetics
|
June 4, 2021
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Hauke Ruehs, Dagmar Klein, Matthias Frei, et al.
Clinical and Translational Science
|
March 29, 2019
Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer
Joachim Grevel, Garrit Jentsch, Rupert Austin, et al.
European Journal of Endocrinology
|
June 12, 2023
Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study
Isabella Gashaw, Stefanie Reif, Herbert Wiesinger, et al.
Hepatology International
|
December 3, 2016
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Shi-Ming Lin, Sheng-Nan Lu, Ping-Tsung Chen, et al.
Molecular Cancer Therapeutics
|
October 18, 2019
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors
Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, et al.
The Lancet. Oncology
|
August 14, 2019
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, et al.
Page
of 1